Mylan Tries To Escape Pharmacy's EpiPen Antitrust Suit

By Meghan Kelly · December 15, 2020, 5:46 PM EST

Mylan Pharmaceuticals has urged a Kansas federal judge to drop it from a suit alleging it inflated the price for the emergency allergy medication EpiPen, arguing the retail and online pharmacy...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Related Sections

Case Information

Case Title

In Re: Epipen (Epinephrine Injection, USP) Marketing, Sales Practices and Antitrust Litigation

Case Number

2:17-md-02785

Court

Kansas

Nature of Suit

Personal Inj. Prod. Liability

Date Filed

August 04, 2017

Case Title

KPH Healthcare Services, Inc. v. Mylan N.V. et al

Case Number

2:20-cv-02065

Court

Kansas

Nature of Suit

Anti-Trust

Date Filed

February 14, 2020

Featured Stories

Healthcare Deals This Week: Oura, AstraZeneca, BMS No Photo Available

Yeji Jesse Lee

It was a week of major deals in the healthcare sector space, with startups like Oura and Kardigan securing significant funding, Bristo... (more story)

State Fraud Units Step Up To Police Medicaid No Photo Available

Hannah Albarazi

The loss of seasoned prosecutors at federal agencies, coupled with the Trump administration’s intense focus on immigration, is undermi... (more story)

Spencer Fane Attys Talk Med Spas And Healthcare Law No Photo Available

Gianna Ferrarin

Providers and investors attracted to a growing medical spa industry might be surprised to discover that aesthetic treatments like Boto... (more story)